UNSPSC 51334203: Metiapine

This classification denotes an antipsychotic agent with the molecular formula C19H21N3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 775D6D91J8, chemically known as 2-methyl-11-(4-methyl-1-piperazinyl)dibenzo(b,f)(1,4)thiazepine but generally known as metiapine, which bears US NIH Compound Identifier 22047. European Medicines Agency schedules Metiapine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08882MIG.

UNSPSC 51334203 Metiapine is a Commodity code that appears in state and local solicitations for pharmaceutical products and medical countermeasures, though recent opportunity records show this particular code tagged to procurement of naloxone and drug deactivation systems rather than metiapine specifically. State and local health departments, county health authorities, and community health agencies use codes in this tier to source controlled pharmaceuticals, emergency medical supplies, and related medical countermeasures that support public health and safety initiatives. The work involves direct purchase of finished pharmaceutical products and medical devices with defined unit quantities, delivery schedules, and compliance requirements tied to controlled-substance handling, workplace certification, and federal funding stipulations when applicable.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2026 at 2:00 pm, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract included a two-year initial term with one-year renewal option, required E-Verify compliance and drug-free workplace certification, and noted potential FEMA funding with associated federal compliance obligations. The source does not identify other recent opportunities under this code or activity across additional jurisdictions or states.